Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis

<p>Abstract</p> <p>Objective</p> <p>To compare the incidence of cardiovascular events and mortality in patients with type 2 diabetes mellitus treated with sitagliptin or non-sitagliptin comparators.</p> <p>Methods</p> <p>A <it>post hoc</...

Full description

Bibliographic Details
Main Authors: Engel Samuel S, Golm Gregory T, Shapiro Deborah, Davies Michael J, Kaufman Keith D, Goldstein Barry J
Format: Article
Language:English
Published: BMC 2013-01-01
Series:Cardiovascular Diabetology
Online Access:http://www.cardiab.com/content/12/1/3